Clinical Trials Directory

Trials / Completed

CompletedNCT02829333

The Effect of Anesthetic Technique on VEGF-C and PGE2

Effect of Anesthetic Technique on Serum Vascular Endothelial Growth Factor C and Prostaglandin E2 in Women Undergoing Surgery for Uterine Leiomyomas

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
44 (actual)
Sponsor
General Hospital of Ningxia Medical University · Academic / Other
Sex
Female
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to verify the effect of anesthetic technique on the change of postoperative serum vascular endothelial growth factor C and prostaglandin E2, and to explore the potential impact of the anesthetic technique on leiomyomas recurrence and growth after the surgery of abdominal myomectomy.

Detailed description

Uterine leiomyomas is the most common benign tumor of uterus, the most common tumor in women as well. Like many other forms of tumor, it requires an independent blood supply to enlarge. This process, angiogenesis, is mediated by vascular endothelial growth factor C (VEGF-C) and prostaglandin E2 (PGE2). Several studies have confirmed that VEGF-C has a high level in patients with uterine leiomyomas, which has also been demonstrated that it was related to occurrence and growth of uterine leiomyomas because it's capable of promoting angiogenesis, mitogenic, and vascular permeability-enhancing activities. Also, some researchers suggested that suppression of prostaglandin synthesis (including PGE2) via cyclooxygenase type-2 (COX-2) enzyme inhibition may reduce the incidence of some tumor. The aim of this study is to verify the effect of anesthetic technique on the change of postoperative serum VEGF-C and PGE2, and to explore the potential impact of the anesthetic technique on leiomyomas recurrence and growth after the surgery of abdominal myomectomy.

Conditions

Interventions

TypeNameDescription
OTHERgeneral anesthesia and patient controlled intravenous analgesiaPatients receive general anesthesia intraoperative period and continuous intravenous analgesia postoperation
OTHERspinal anesthesia and continuous postoperative epidural analgesiaPatients receive spinal anesthesia intraoperative period and continuous epidural analgesia postoperation

Timeline

Start date
2015-05-01
Primary completion
2016-04-01
Completion
2016-04-01
First posted
2016-07-12
Last updated
2020-01-22

Source: ClinicalTrials.gov record NCT02829333. Inclusion in this directory is not an endorsement.